Global Perspectives on Leukemia – Consensus in ALL

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding acute lymphocytic leukemia

August 23, 2021

Faculty Chair

Elias Jabbour, MD

The University of Texas MD Anderson Cancer Center, Houston, TX, USA


Ibrahim Aldoss, MD
City of Hope, Duarte, CA, USA

Patrick Brown, MD
Johns Hopkins, Baltimore, MD, USA

Aaron Logan, MD, PhD
University of California, San Francisco, CA, USA

Bijal Shah, MD, MS
H. Lee Moffitt Cancer Center, Tampa, FL, USA

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Wendy Stock, MD
University of Chicago, Chicago, IL, USA

Lori Muffly, MD, MS
Stanford Cancer Center, Palo Alto, CA

Sample Report

Start discovering the insights

View Report


  • MRD in ALL
  • Bispecific Approaches in ALL
  • Anti-CD19 CAR Ts in ALL
  • Case-Based Discussion on Therapy Decisions in ALL
  • Generation of an Algorithm

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.